Company News
-
April 17, 2025
bioMérieux Embarks its Customers in a Circular Economy Initiative
BIOLOOP™ is an innovative project to recycle plastic Petri dishes from infectious waste into new reagents packaging—reducing CO₂ emissions and supporting a circular economy in healthcare. -
April 10, 2025
bioMérieux partners with Mila to harness artificial intelligence for diagnostics
This partnership aims to develop innovative solutions to improve the accuracy and efficiency of in vitro diagnostic tools and detection of antibiotic resistance. -
February 24, 2025
bioMérieux and Vall d'Hebron Join Forces Against Infectious Diseases
bioMérieux announces a new strategic research partnership with Vall d'Hebron, one of Spain's largest and most prestigious healthcare institutions. This collaboration aims to advance research and development in the areas of infectious diseases, data surveillance, and laboratory automation. -
February 20, 2025
bioMérieux acquires Neoprospecta, a Brazil-based company dedicated to data and genomics solutions for microbial risk management in food and pharma industries
bioMérieux, a world leader in the field of in vitro diagnostics, has finalized the closing of the acquisition of Neoprospecta on January 29th, 2025. A Sale and Purchase Agreement (SPA) to acquire this Brasilian-based company was signed in November 2024. Neoprospecta, based in Florianopolis, develops and markets innovative user-friendly data and genomics solutions for augmenting quality assurance programs and improve microbiological risk prevention in food and pharma industries. -
November 22, 2024
bioMérieux and St James’s Hospital in Ireland announce the world-first Data & IT Centre of Reference partnership
On November 14th, 2024, bioMérieux officially launched its first Data & IT Centre of Reference partnership with St James's Hospital in Dublin, Ireland. This landmark collaboration has been celebrated with an event held at the Davis Coakley Lecture Theatre, St James's Hospital.
